New meningitis vaccine trial aims to protect against deadly infection
⭐️ VACCINE ⭐️
Recruiting now
This study tests a new vaccine called GNG-DE to see how well it protects against meningococcal disease, a serious infection that can cause meningitis and sepsis. About 240 healthy people aged 3 to 55 will receive either the new vaccine or a reference vaccine. Researchers will mea…
Phase: PHASE3 • Sponsor: NPO Petrovax • Aim: ⭐️ VACCINE ⭐️
Last updated May 13, 2026 16:08 UTC